SCHEMBL1669079

SCHEMBL1669079

CS(=O)(=O)N1CCC(c2cc(F)c(OC3CN(Cc4noc(C(F)(F)F)n4)C3)c(F)c2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
KMT2A Q03164 1/20 0.38
RORC P51449 1/20 0.34
GPR119 Q8TDV5 6/20 0.34
NPY5R Q15761 1/20 0.33
HDAC4 P56524 1/20 0.33
IDO1 P14902 1/20 0.33
HTT P42858 3/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
RBP4 P02753 1/20 0.32
MIF P14174 1/20 0.32
FPR2 P25090 1/20 0.31
PROKR1 Q8TCW9 1/20 0.31
PDE4B Q07343 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1669061 0.93 GPR119 (0.39) LMNAKMT2ARORCGPR119NPY5R
SCHEMBL1669106 0.93 CNR2 (0.35) LMNAKMT2ARORCGPR119NPY5R
SCHEMBL1668511 0.87 GPR119 (0.45) LMNAKMT2ARORCGPR119NPY5R
SCHEMBL12198409 0.85 MIF (0.33) HDAC4HTTHDAC1HDAC8HDAC6
SCHEMBL1668891 0.84 GPR119 (0.48) LMNAKMT2ARORCGPR119NPY5R
SCHEMBL1668540 0.83 IDO1 (0.39) LMNAKMT2ARORCGPR119NPY5R
SCHEMBL1669280 0.82 GPR119 (0.42) LMNAKMT2ARORCGPR119NPY5R
SCHEMBL1669001 0.81 GPR119 (0.41) LMNAKMT2ARORCGPR119NPY5R
SCHEMBL1669002 0.81 HTT (0.41) LMNAKMT2ARORCGPR119NPY5R
SCHEMBL1668410 0.79 KDM4E (0.49) LMNAKMT2ARORCGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US claimed
EP-2486033-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2012-08-15 EP claimed
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-10-06 US claimed
WO-2011044001-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-04-14 WO claimed
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US disclosed
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US disclosed
EP-2486033-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2012-08-15 EP disclosed
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-10-06 US disclosed
WO-2011044001-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR65, GPR39 LMNA 3232/4885KMT2A 3355/4885RORC 361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.